Expertise in
5
conditions

John M. Wentworth

99 Commercial Road, 
Melbourne, VIC, AU 
Expertise in
5
conditions
99 Commercial Road, 
Melbourne, VIC, AU 

Overview

John Wentworth practices practicing medicine in Melbourne, Australia.

Mr. Wentworth is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Obesity, Type 2 Diabetes (T2D), Neurohypophyseal Diabetes Insipidus, and Endoscopy.

He is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

99 Commercial Road, Melbourne, VIC 3004, Australia
Other Locations
St Vincent's Hospital Melbourne, Fitzroy, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomised, Placebo Controlled Study Investigating the Efficacy of Baricitinib in New Onset Type 1 Diabetes Mellitus
A Phase 2, Randomised, Placebo Controlled Study Investigating the Efficacy of Baricitinib in New Onset Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: December 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

117 Total Publications

β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes.
β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes.
Journal: Diabetes care
Published: May 06, 2026

Frequently Asked Questions about John M. Wentworth

Is John M. Wentworth a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. John M. Wentworth is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does John M. Wentworth participate in research or clinical trials?

Yes. John M. Wentworth has published 117 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of John M. Wentworth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wentworth's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile